Recognition and control of virus infections | Pandemic PACT Tracker

Key facts

Disease
COVID-19
start year
-99
Known Financial Commitments (USD)
$3,638,696.72
Funder
UK Research and Innovation (UKRI)
Principal Investigator
Dr. P Beard
Research Location
United Kingdom
Lead Research Institution
The Pirbright Institute
Research Priority Alignment
N/A

Research Category
N/A
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

PI: Enhanced host responses for disease control: a BBSRC Strategic Programme

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.

Authors
Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, Akech D, Karia B, Ziraba AK, Maina A, Lambisia A, Omuoyo D, Mugo D, Lucinde R, Owuor S, Konyino G, Newman J, Bailey D, Nduati E, Githinji G, Agoti CN, Bejon P, Scott JAG, Agweyu A, Kagucia W, Warimwe GM, Sande C, Ochola-Oyier LI, Nyagwange J.
Publish Year
2024
Journal
BMC infectious diseases
DOI
10.1186/s12879-024-10367-3

View at Europe PMC

A broadly reactive ultralong bovine antibody that can determine the integrity of foot-and-mouth disease virus capsids.

A genome assembly and transcriptome atlas of the inbred Babraham pig to illuminate porcine immunogenetic variation.

One-pot Golden Gate Assembly of an avian infectious bronchitis virus reverse genetics system.

Single-cell analysis reveals lasting immunological consequences of influenza infection and respiratory immunization in the pig lung.

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, and JN.1.4, using samples from two health demographic surveillance systems in Kenya

Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86

Authors
Turner S, Amirthalingam G, Bailey D, Barouch DH, Bewley KR, Brown K, Cao Y, Chan Y, Charlton S, DOVE consortium, Coombes NS, Hallis B, Ho DD, Jian F, Lasrado N, Lassaunière R, Liu L, Montefiori DC, Moss P, Newman J, Parry H, Polacek C, Rasmussen M, Shao F, Shen X, Thakur N, Thomson EC, Wang J, Wang P, Wang Q, Willett BJ, Yisimayi A, Smith DJ.
Publish Year
2024
DOI
10.1101/2024.03.27.586820

View at Europe PMC

The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge.

Distinct effector functions mediated by Fc regions of bovine IgG subclasses and their interaction with Fc gamma receptors.